PRESS RELEASE published on 07/01/2026 at 09:22, 1 month 14 days ago Inside Information / Other news releases Valerio Therapeutics announces binding offer to acquire Etherna Immunotherapies, creating global leader in targeted RNA medicines. Strategic move unlocked by leading investors Acquisition Valerio Therapeutics RNA Medicines Targeted Delivery Etherna Immunotherapies
PRESS RELEASE published on 07/01/2026 at 09:22, 1 month 14 days ago Informations privilégiées / Autres communiqués Valerio Therapeutics annonce l'acquisition d'Etherna Immunotherapies, devenant ainsi un leader mondial des médicaments à base d'ARN ciblés. L'opération vise à combiner deux technologies pour le développement de nouveaux traitements Acquisition Innovation Biotechnologie Valerio Therapeutics Médicaments ARN Ciblés
BRIEF published on 06/16/2026 at 19:48, 1 month 28 days ago Valerio Therapeutics nomme un nouveau PDG et confirme les résolutions de son assemblée générale annuelle Biotechnologie Transition Du PDG Valerio Thérapeutique Gilles Besin Médicaments À Base D'ARN
BRIEF published on 06/16/2026 at 19:48, 1 month 28 days ago Valerio Therapeutics Appoints New CEO and Confirms AGM Resolutions Biotechnology CEO Transition Valerio Therapeutics Gilles Besin RNA Medicines
PRESS RELEASE published on 06/16/2026 at 19:43, 1 month 28 days ago Informations privilégiées / Autres communiqués Valerio Therapeutics nomme Gilles Besin au poste de Directeur Général et annonce les résultats de son Assemblée Générale Annuelle, marquant une nouvelle phase d'innovation dans les thérapies ciblées de précision Biotechnologie Assemblée Générale Directeur Général Valerio Therapeutics Gilles Besin
PRESS RELEASE published on 06/16/2026 at 19:43, 1 month 28 days ago Inside Information / Other news releases Valerio Therapeutics appoints Gilles Besin as CEO, approved all resolutions at annual general meeting. Besin brings deep RNA and targeted delivery expertise to drive innovation Annual General Meeting Valerio Therapeutics Gilles Besin RNA Medicines Targeted Delivery
BRIEF published on 12/17/2025 at 11:02, 7 months 29 days ago Valerio Therapeutics Accueille le Professeur Eric Vivier au Conseil d'Administration Conseil D'administration Oncologie Valerio Therapeutics Immunologie Eric Vivier
BRIEF published on 12/17/2025 at 11:02, 7 months 29 days ago Valerio Therapeutics nomme le professeur Eric Vivier observateur au conseil d'administration Conseil D'administration Valerio Thérapeutique Immunologie Professeur Eric Vivier Stratégie En Oncologie
BRIEF published on 12/17/2025 at 11:02, 7 months 29 days ago Valerio Therapeutics Welcomes Professor Eric Vivier to its Board of Directors Board Of Directors Oncology Immunology Valerio Therapeutics Eric Vivier
BRIEF published on 12/17/2025 at 11:02, 7 months 29 days ago Valerio Therapeutics Appoints Professor Eric Vivier as Board Observer Board Of Directors Immunology Valerio Therapeutics Professor Eric Vivier Oncology Strategy
Published on 08/15/2026 at 00:50, 12 hours 56 minutes ago Revive Therapeutics Reports Grant of Options
Published on 08/15/2026 at 00:15, 13 hours 31 minutes ago Full Circle Lithium Announces Closing of Private Placement
Published on 08/14/2026 at 23:45, 14 hours 1 minute ago AI/ML Innovations Inc. Announces Proposed Private Placement
Published on 08/14/2026 at 23:25, 14 hours 21 minutes ago NuRAN Wireless Closes $7.6 Million Financing
Published on 08/14/2026 at 23:00, 14 hours 46 minutes ago Medicure Reports Financial Results for Quarter Ended June 30, 2026 and Schedules August 17, 2026 Conference Call
Published on 08/15/2026 at 08:05, 5 hours 41 minutes ago SKYWORTH Solar to Launch SolaMate Balcony Solar System on Joybuy Germany on August 15
Published on 08/14/2026 at 18:15, 19 hours 31 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/14/2026 at 16:05, 21 hours 41 minutes ago GATORADE WELCOMES AITANA BONMATÍ TO TEAM GATORADE AHEAD OF THE NEW FOOTBALL SEASON
Published on 08/13/2026 at 18:00, 1 day 19 hours ago Chiffre d’affaires du 1er trimestre 2026-27 : 14,4 M€
Published on 08/11/2026 at 17:45, 3 days 20 hours ago DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 3 days 20 hours ago Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 4 days 19 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 4 days 19 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
